
Science 37
#7980
Rank
$34.66M
Marketcap
United States
Country

Mr. David Coman (CEO & Director)
Ms. Christine A. Pellizzari J.D. (Chief Legal & HR Officer and Sec.)
Mr. Mike Zaranek (Chief Financial Officer)
Summary
History
Science 37 was founded in 2014 by Noah Craft and Belinda Tan, working out of LA BioMed at Harbor-UCLA Medical Center. Their team developed the Network Oriented Research Assistant platform, also known as the NORA platform, which includes video chat, digital self-photography, data collection, and electronic consent. Together, these features were used to conduct “site-less” trials. The platform also aided researchers in finding and contacting potential participants, and scheduling trial participants for in-home activities like questionnaires, mobile nurse visits, and door-step study medicine delivery. The Operating System, as it is now known, is configurable to enable any type of study, in any indication. This industry-leading platform can be customized to activate and operationalize even the most complex clinical trials.
Science 37 received its initial round of funding in 2015, with a $6.5 million investment, co-led by Lux Capital and dRx Capital. In 2016 the company's second round of financing resulted in $31 million in funding, and a 2017 round of financing resulted in $29 million. In March 2019, Science 37 secured $35 million in Series D funding; and announced a leadership transition with David Coman coming in as CEO in November 2019. In August 2020 Science 37 closed an oversubscribed Series D $40 million funding round led by Lux Capital, Redmile Group, and PPD, Inc. . In May 2021, Science 37 announced that they are to become publicly listed via merger with LifeSci Acquisition II Corp. The transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing. It also positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research.
Mission
Vision
Key Team
Troy Bryenton (Chief Technology Officer)
Ms. Darcy Forman (Chief Delivery Officer)
Ms. Elisa Cascade (Chief Product Officer)
Ms. Margie Gimbel Kooman (VP of Marketing & Communications)
Mr. Drew Bustos (Chief Strategy & Marketing Officer)
Mr. Jonathan Cotliar M.D. (Chief Medical Officer)
Mr. Michael Shipton (Chief Commercial Officer)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Mr. David Coman (CEO & Director)
Ms. Christine A. Pellizzari J.D. (Chief Legal & HR Officer and Sec.)
Mr. Mike Zaranek (Chief Financial Officer)
